Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages

  Ryu, Sang Young ^a   Lee, Won Moo ^a   Kim, Kidong ^a   Park, Sang Il ^b   Kim, Beob Jong ^a   Kim, Moon Hong ^a   Choi, Seok Cheol ^a   Cho, Chul Koo ^a   Nam, Byung Ho ^c   Lee, Eui Don ^b  

^a Korea Cancer Center Hospital   (South Korea)

^b Dongnam Institute of Radiological and Medical Science   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

Locally advanced cervical cancer; Tri weekly cisplatin based chemoradiation therapy

Indexed keywords

CERVICAL CANCERS; CIS-PLATIN; CONFIDENCE INTERVAL; HAZARD RATIO; NEUTROPENIA; OVERALL SURVIVAL RATES; RANDOMIZED CLINICAL TRIALS; RANDOMIZED TRIAL; STATISTICALLY SIGNIFICANT DIFFERENCE; SURVIVAL RATE; TRI-WEEKLY CISPLATIN-BASED CHEMORADIATION THERAPY;

CHEMOTHERAPY; DISEASES; MEDICAL COMPUTING; RADIOTHERAPY; TOXICITY;

PLATINUM COMPOUNDS;

CISPLATIN;

ADULT; ADVANCED CANCER; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG TOLERANCE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY NEUROPATHY; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VOMITING;

ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; SODIUM CHLORIDE; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 81155160980     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.05.002     Document Type: Article

References (17)

1. A.A. Garcia, J.A. Blessing, and K.M. Darcy Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: A Gynecologic Oncology Group study Gynecol Oncol 104 2007 572 579 (Pubitemid 46240236)
2. H.M. Keys, B.N. Bundy, and F.B. Stehman Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161 (Pubitemid 29177874)
3. M. Morris, P.J. Eifel, and J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143 (Pubitemid 29177872)
4. W.A. Peters 3rd, P.Y. Liu, and R.J. Barrett 2nd Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613 (Pubitemid 30220538)
5. P.G. Rose, B.N. Bundy, and E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153 (Pubitemid 29177873)
6. C.W. Whitney, W. Sause, and B.N. Bundy Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348 (Pubitemid 29220838)
7. J.A. Green, J.M. Kirwan, and J.F. Tierney Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis Lancet 358 2001 781 786 (Pubitemid 32868726)
8. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials J Clin Oncol 26 2008 5802 5812
9. J.M. Kirwan, P. Symonds, and J.A. Green A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer Radiother Oncol 68 2003 217 226 (Pubitemid 38373421)
10. R. Lanciano, A. Calkins, and B.N. Bundy Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: A gynecologic oncology group study J Clin Oncol 23 2005 8289 8295
11. R. Pearcey, M. Brundage, and P. Drouin Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix J Clin Oncol 20 2002 966 972 (Pubitemid 34141839)
12. A. Mitsuhashi, T. Uno, and N. Tanaka Phase I study of daily cisplatin and concurrent radiotherapy in patients with cervical carcinoma Gynecol Oncol 96 2005 194 197 (Pubitemid 39612436)
13. Y. Watanabe, H. Nakai, and M. Shimaoka Feasibility of concurrent cisplatin use during primary and adjuvant chemoradiation therapy: A phase I study in Japanese patients with cancer of the uterine cervix Int J Clin Oncol 11 2006 309 313 (Pubitemid 44306215)
14. P. Bonomi, J.A. Blessing, and F.B. Stehman Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study J Clin Oncol 3 1985 1079 1085 (Pubitemid 15004828)
15. T. Thigpen, H. Shingleton, and H. Homesley cis- Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: Phase II trials by the Gynecologic Oncology Group Cancer Treat Rep 63 1979 1549 1555 (Pubitemid 10167754)
16. H. Ikushima, K. Osaki, and S. Furutani Chemoradiation therapy for cervical cancer: Toxicity of concurrent weekly cisplatin Radiat Med 24 2006 115 121
17. B. Chumworathayi, P. Suprasert, and K. Charoenkwan Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: A randomized comparison of treatment compliance J Med Assoc Thai 88 2005 1483 1492 (Pubitemid 44698958)